Anabolic Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 7 Year, 23 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 125.75%
(FY 2020)
- Profit 128.95%
(FY 2020)
- Ebitda 104.20%
(FY 2020)
- Net Worth 52.21%
(FY 2020)
- Total Assets 7.00%
(FY 2020)
About Anabolic Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Raj Gupta and Vijay Gupta serve as directors at the Company.
- CIN/LLPIN
U24304CH2018PTC041822
- Company No.
041822
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jan 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Anabolic Remedies Private Limited offer?
Anabolic Remedies Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Ayurvedic,Herbal Products & Medicine, Herbal Piles Medicine, Ayurvedic Herbal Syrups & Tonics, Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Common Disease Medicines, Pharmaceutical Medicine, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Anabolic Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Gupta  | Director | 01-Jan-2018 | Current |
| Vijay Gupta | Director | 12-Aug-2021 | Current |
Financial Performance of Anabolic Remedies.
Anabolic Remedies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 125.75% increase. The company also saw a substantial improvement in profitability, with a 128.95% increase in profit. The company's net worth Soared by an impressive increase of 52.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anabolic Remedies?
Unlock access to Anabolic Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anabolic Remedies?
Unlock and access historical data on people associated with Anabolic Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anabolic Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anabolic Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
